Skip to main content

Table 4 Meta-regression for 30-day mortality

From: Glycoprotein IIb/IIIa inhibitors for cardiogenic shock complicating acute myocardial infarction: a systematic review, meta-analysis, and meta-regression

 

n

I2

Qdf (p)

Coef (p)

Age

5

61.32%

7.323 (0.062)

− 0.307 (0.210)

Gender

6

51.72%

8.724 (0.068)

4.475 (0.169)

Diabetes mellitus

6

68.09%

10.424 (0.034)

− 0.849 (0.708)

Hypertension

3

85.10%

6.711 (0.010)

6.832 (0.387)

Tobacco use

4

81.47%

8.1112 (0.017)

6.774 (0.456)

Invasive ventilation

5

77.08%

10.6143 (0.014)

− 0.165 (0.893)

TIMI flow 0/1 pre procedure

5

77.28%

10.6813 (0.014)

− 0.288 (0.807)

IABP use*

6

0.00%

3.7624 (0.439)

− 1.565 (0.005)

LVEF

3

0.00%

0.0021 (0.989)

− 0.665 (0.368)

Left main stenosis

4

41.01%

3.2792 (0.194)

− 15.572 (0.851)

  1. n number of studies included in the analysis, TIMI thrombolysis in myocardial infarction, IABP intraortic balloon pump, LVEF left ventricular ejection fraction